SCHEMBL974786

SCHEMBL974786

C#CC(=O)N(C)CCN(C)c1nccs1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.37
FFAR2 O15552 1/20 0.34
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
HTR7 P34969 1/20 0.33
NR3C1 P04150 1/20 0.32
HDAC1 Q13547 2/20 0.32
TRPM8 Q7Z2W7 2/20 0.31
GLS O94925 1/20 0.30
FFAR1 O14842 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL971740 0.78 NPSR1 (0.47) PPARGFFAR2NR3C1HDAC1TRPM8
SCHEMBL971722 0.76 GRM5 (0.40) PPARGALDH1A1NR3C1HDAC1FFAR1
SCHEMBL8229257 0.75 SLC6A7 (0.44) SCN1ASCN2ASCN3ANR3C1TRPM8
SCHEMBL973396 0.74 GRM5 (0.39) PPARGGAATSHRTRPM8FFAR1
SCHEMBL972388 0.73 GRM5 (0.40) TSHRFFAR1
SCHEMBL971987 0.73 GRM5 (0.41) PPARGFFAR2ALDH1A1GAATSHR
SCHEMBL8228108 0.73 GAA (0.45) ALDH1A1GAAHDAC1LMNA
SCHEMBL3022750 0.73 POLB (0.44) PPARGFFAR2ALDH1A1TSHRSCN1A
SCHEMBL14024208 0.71 NPSR1 (0.45) PPARGFFAR2ALDH1A1NR3C1HDAC1
SCHEMBL4723832 0.71 HTR7 (0.42) PPARGFFAR2ALDH1A1TSHRSCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871999-B2 Substituted thiazoles and their use for producing drugs GRUENENTHAL GMBH (DE) 2011-01-18 US disclosed
EP-1968957-B1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2010-01-20 EP disclosed
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-07-09 US disclosed
WO-2007079960-A9 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS GRUENENTHAL GMBH (DE) 2008-10-23 WO disclosed
EP-1968957-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079960-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176756-A1 SUBSTITUTED THIAZOLES AND THEIR USE FOR PRODUCING DRUGS TPMT, SLC5A2, DPP4 PPARG 62/4885FFAR2 2613/4885ALDH1A1 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.